Why Aren’t People Sticking With Semaglutides?
Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the medication within a year, according to a large population-based study out of Denmark.
The discontinuation rate rose from 18% at 3 months to 52% at 12 months, Reimar Thomsen, MD, PhD (Aarhus University Hospital, Denmark), reported this week at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria.
Younger people, men, and those with lower incomes, higher comorbidity burdens, and past use of psychiatric and GI medications were more likely to go off treatment than others.
Excerpted from tctMD
